HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Doherty Selected Research

Uric Acid (Urate)

1/20172016 updated EULAR evidence-based recommendations for the management of gout.
1/2017Treat-to-target (T2T) recommendations for gout.
9/2015Identification of patients with gout: elaboration of a questionnaire for epidemiological studies.
6/2013Patients with gout adhere to curative treatment if informed appropriately: proof-of-concept observational study.
6/2008A modified Delphi exercise to determine the extent of consensus with OMERACT outcome domains for studies of acute and chronic gout.
10/2006EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).
10/2006EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Doherty Research Topics

Disease

14Osteoarthritis
01/2022 - 09/2002
14Pain (Aches)
01/2021 - 01/2002
9Knee Osteoarthritis
01/2021 - 08/2000
8Gout
01/2017 - 10/2006
5Arthritis (Polyarthritis)
09/2015 - 01/2009
3Inflammation (Inflammations)
01/2017 - 06/2008
3Hip Osteoarthritis (Coxarthrosis)
01/2016 - 11/2000
3Chondrocalcinosis (Pseudogout)
11/2014 - 08/2004
3Weight Loss (Weight Reduction)
02/2008 - 10/2001
2Neoplasms (Cancer)
01/2022 - 12/2011
2Osteophyte
01/2021 - 08/2000
2Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 10/2006
2Hemorrhage
01/2021 - 04/2010
2Hypertrophy
01/2017 - 04/2010
2Wounds and Injuries (Trauma)
11/2011 - 01/2000
2Crystal Arthropathies
04/2011 - 04/2011
2Rheumatic Diseases (Rheumatism)
04/2011 - 09/2007
2Obesity
10/2006 - 01/2000
2Infections
02/2004 - 08/2000
1Carcinoid Tumor (Carcinoid)
01/2022
1Synovitis
01/2021
1Anorexia
12/2020
1Hand-Foot Syndrome
12/2020
1Hepatocellular Carcinoma (Hepatoma)
12/2020
1Diarrhea
12/2020
1Breast Neoplasms (Breast Cancer)
01/2019
1Disease Progression
01/2019
1Tuberculosis (Tuberculoses)
04/2015
1Vascular Calcification
11/2014
1Cyanosis
08/2013
1Hypoxia (Hypoxemia)
08/2013
1Hydrocephalus (Hydrocephaly)
02/2013
1Mumps
02/2013
1Meningoencephalitis
02/2013
1Postoperative Nausea and Vomiting (PONV)
07/2012
1Dehydration (Water Stress)
07/2012
1Dizziness (Lightheadedness)
07/2012
1Knee Injuries (Knee Injury)
11/2011
1Tendon Injuries
11/2011
1Genetic Predisposition to Disease (Genetic Predisposition)
05/2010
1Arthralgia (Joint Pain)
06/2008

Drug/Important Bio-Agent (IBA)

8Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021 - 02/2000
7Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021 - 09/2002
7Uric Acid (Urate)IBA
01/2017 - 10/2006
3Biomarkers (Surrogate Marker)IBA
01/2017 - 01/2009
2Hormones (Hormone)IBA
01/2019 - 01/2001
2Capsaicin (Zostrix)FDA Link
12/2018 - 02/2008
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2011 - 02/2008
26-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
04/2011 - 04/2011
2ChondroitinIBA
04/2010 - 02/2008
2Glucosamine (Dona)IBA
04/2010 - 02/2008
2purineIBA
10/2006 - 10/2006
2DiureticsIBA
10/2006 - 10/2006
2GlycogenIBA
04/2001 - 01/2001
1GoldIBA
01/2022
1avelumabIBA
01/2022
1ORALIT (ORS)IBA
01/2021
1Analgesics (Analgesic Drugs)IBA
01/2021
1Sorafenib (BAY 43-9006)FDA Link
12/2020
1cabozantinibIBA
12/2020
13-methoxybutylcyanoacrylateIBA
01/2019
1Substance PIBA
01/2017
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
01/2017
1PegloticaseFDA Link
01/2017
1NeuropeptidesIBA
01/2017
1GlucocorticoidsIBA
01/2016
1MineralsIBA
11/2014
1CalciumIBA
11/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
05/2014
1IodineIBA
08/2013
1VaccinesIBA
02/2013
1Crystalloid SolutionsIBA
07/2012
1ElementsIBA
12/2011
1Biological ProductsIBA
12/2011
1SteroidsIBA
04/2011
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
04/2011
1Calcium PyrophosphateIBA
04/2011
1Methotrexate (Mexate)FDA LinkGeneric
04/2011
1ColchicineFDA LinkGeneric
04/2011
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
03/2011
1Interleukin-1beta (Interleukin 1 beta)IBA
03/2011
1Interleukin-6 (Interleukin 6)IBA
05/2010
1CytokinesIBA
05/2010
1ClenbuterolIBA
04/2010
1Hyaluronic Acid (Hyaluronan)IBA
04/2010
1von Willebrand FactorIBA
12/2009
1Growth Differentiation Factor 5IBA
12/2009
15'-deoxy-5'-thioadenosine 5'-monophosphate (ASMP)IBA
02/2009
1Aspartic Acid (Aspartate)FDA Link
10/2008
1diacereinIBA
02/2008

Therapy/Procedure

12Therapeutics
01/2022 - 10/2001
3Meniscectomy
11/2014 - 04/2010
2Drug Therapy (Chemotherapy)
12/2011 - 02/2004
2Exercise Therapy (Therapy, Exercise)
06/2005 - 10/2001
1Immunotherapy
01/2022
1Replacement Arthroplasty
10/2013
1Analgesia
09/2013
1Ambulatory Surgical Procedures (Outpatient Surgery)
07/2012
1Resistance Training
04/2010
1Injections
12/2008